Biểu đồ giá cổ phiếu SRRK
SRRK Cổ tức
Scholar Rock Holding Corp
$49.19
3.92%
$1.85
Khi đóng cửa: Jun 22, 16:00:00 GMT-4
$48.85
-0.69%
$-0.33
Phiên trước giờ: Jun 23, 07:36:17 GMT-4
Quay lại
Scholar Rock Holding Corp (SRRK) Cổ tức
Thống kê chính
Giá đóng cửa trước
$47.33
Giá mở cửa
$47.95
Phạm vi ngày
$47.73 - $49.82
Phạm vi 52 tuần
$27.07 - $52.18
Khối lượng
1.5M
Khối lượng trung bình
1.3M
Tỷ suất cổ tức
--
EPS (TTM)
-3.45
Vốn hóa thị trường
$5.8B
SRRK là gì?
Scholar Rock Holding Corp. is a biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 289 full-time employees. The company went IPO on 2018-05-24. The firm focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe and debilitating neuromuscular diseases. Its pipeline product candidates include apitegromab, a subcutaneous formulation of apitegromab, and SRK-439. The Apitegromab is an investigational fully human, intravenously administered monoclonal antibody designed to inhibit myostatin activation by selectively binding the pro- and latent forms of myostatin in the skeletal muscle. The SRK-439, is an investigational, subcutaneously administered fully human anti-pro/latent myostatin antibody that has high inhibitory potency while maintaining selectivity towards myostatin. Its early-stage pipeline includes additional programs for the treatment of patients with rare, severe, and debilitating neuromuscular diseases.
